secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001493152-25-021389
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XTNT stockholders approve 12.3M share increase to 2023 equity plan at annual meeting
--------------------------------------------------------------------------------

- 12,300,000 additional shares approved for 2023 Equity Incentive Plan, effective immediately.
- Six director nominees elected with over 79M votes for each; no changes to board composition.
- Ratification of Grant Thornton as auditor for FY 2025; advisory vote on exec compensation approved.
- Stockholders voted 78.7M for 'every one year' frequency for future say-on-pay votes.
- Quorum of 69.2% (96.9M shares) present at meeting held Nov 7, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315225021389/0001493152-25-021389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315225021389/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer